Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy
Monday, October 19, 2009 - 01:14
in Health & Medicine
The human genetic disease dyskeratosis congenita (DKC) is an autosomal dominant disease that leads to abnormalities in tissues with a rapid cell turnover -- the skin, nails, bone marrow, lungs and gut. Patients with DKC experience life-threatening symptoms. Bone marrow failure increases their risk of fatal infections and cancer.